Skip to main content

Table 2 Inclusion and exclusion criteria for determining eligible studies

From: Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol

  Inclusion criteria Exclusion criteria
Language English None English language studies
Population People living with HIV (PLWH) Studies which do not focus on PLWH or do not include PLWH
Period Studies published from 1 January 1996 to 30 June 2019 Studies published before January 1996
Type of studies Primary and secondary studies Review articles (including systematic review and meta-analysis)
However, reference list from review articles will be searched for further eligible studies
Studies designs Quantitative
Qualitative
Mixed methods
Randomized controlled trial
Cohort study (prospective observational study)
Case-control study
Cross-sectional study
Case reports and series
Ideas, editorials, opinions
Crossover design
Animal research studies
Test-tube lab research
Study focus Studies that report on either of the following:
• Prescription drug diversion
• Prescription drug misuse
• Prescription drug abuse
• Recreational/non-medical use/misuse/abuse/illicit/selling/trading/sharing/giving away/stealing/losing, and doctor shopping of prescribed drugs
• Prevalence of prescription drug diversion, misuse or abuse
• Practices of prescription drug diversion, misuse or abuse
• Motives (other terms such as reasons, cause, purpose, intention, motivation, drive, and aim maybe used) of prescription drug diversion, misuse, or abuse
• Risk factors of prescription drug diversion, misuse, or abuse
• ART adherence
Studies that do not focus or report on the following:
• Prescription drug diversion, misuse or abuse
• Prevalence, practices, motives, risk factors and ART adherence associated with prescription drug diversion, misuse or abuse
Drug classes Studies that report on diversion, misuse, and abuse of the below drug classes:
• Sedatives—including barbiturates, benzodiazepines, and sleep medications
• Analgesics—including opioids heroin, morphine, hydromorphone, meperidine, oxycodone, hydrocodone, oxycodone, buprenorphine, methadone, fentanyl, and codeine
• Stimulants—including cocaine, methamphetamine, amphetamine, and methylphenidate
• Z-drugs (nonbenzodiazepines)—including imdazopyridines, cycloprrolones, pyrazolopyridines, and sleep medication
• Anesthetic drugs
• Antiretroviral drugs
• Attention deficit hyperactivity disorder (ADHD) medication
• Cannabinoids
Studies that report on diversion, misuse, and abuse of the below drug classes will be excluded:
• Ecstasy drug—since it has no accepted medical indication